ArticleCurrent developments in nutrition2025
Validation Study of Adherence to Daily Multiple Micronutrient Supplementation by Palestine Refugee Women Attending United nations Relief and Works Agency for Palestine Refugees in the Near East Health Clinics in Jordan.
Article in Current developments in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple micronutrient supplementation (MMS) is a new standard of antenatal care emerging in lower-income countries. Assessing adherence, a key implementation outcome, requires validation. Objectives: Validate antenatal adherence to daily MMS based on recalled tablet days missed during follow-up intervals in UNRWA clinics serving Palestine refugees in Jordan. Methods: This study was conducted during an implementation trial of antenatal MMS versus standard-of-care iron-folic acid supplementation. In 13 clinics, at registration, pregnant women received daily MMS in 180-count bottles weighing 111 g (bottle with desiccant = 26 g, tablet = 0.47 g). At seven follow-up visits, returning bottles were weighed to nearest gram on digital scales, and recalled tablet days missed were recorded. Tablets removed from bottles, estimated from bottle weight decrements, were regressed on tablets taken, obtained by subtracting tablet days missed from interval lengths. Similar analyses were conducted for cumulative intervals since registration. Results: Among 9754 registered women, 7608 (78%), 6,208 (63.6%), 4,833 (49.5%), 3,409 (34.9%), 2159 (22.1%), 1063 (10.9%), and 384 (3.9%) completed the first-to-seventh follow-up visits, respectively, with a decline mainly due to censoring at close-out. Approximately 25% of women failed to return bottles, whose tablet intakes were modestly lower than those of bottle-returnees. Notwithstanding, 75 to 84% in both groups recalled missing <2 d and <5.3% missing >30 d. Interval-specific regression slopes (β Conclusions: Histories of recalled tablet days missed provide a reliable and reasonably valid estimate of tablet disappearance from MMS bottles. Further research is warranted to correct a consistently reported ∼20% average overestimate of tablet intake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.